Additionally, Escherichia coli stably transformed with a plasmid constitutively expressing nanobody antagonist against CD47 could stimulate systemic tumor antigen-specific immune responses, and induced durable tumor regression and long-term survival in a syngeneic tumor model (119). This evidence concerns the gene CD47 and neoplasm.